Last $1.60 USD
Change Today +0.05 / 3.23%
Volume 32.2K
VRML On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 10/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jean-François Formela M.D., MBA

AgeTotal Calculated CompensationThis person is connected to 150 board members in 20 different organizations across 26 different industries.

See Board Relationships
57--

Background*

Dr. Jean-François Formela, M.D., MBA is a Partner at Atlas Venture L.P. Mr. Formela is a part of the life sciences group and focuses on new advances in biology and drug discovery technologies as well as novel therapeutics. He serves as an Executive at Vermillion, Inc. He joined Atlas Venture in 1993 and served as a Principal from 1993 to 1995. Prior to joining Atlas Venture, Dr. Formela served as a senior director of medical marketing and scientific affairs at Schering-Plough ...

Read Full Background

Corporate Headquarters*

Building III
Austin, Texas 78738

United States

Phone: 512-519-0400
Fax: 512-439-6980

Board Members Memberships*

Director
Director
Chairman
Director
Director
Former Director
Director
Director
Director
Director
Director
Director
Director
Director
Director
1995-2005
Former Director
1996-2005
Former Director
1997-N/A
Former Director
1997-Present
Director
1999-N/A
Director, Member of Compensation Committee and Member of Corporate Governance & Nominating Committee
2000-2008
Former Director and Member of Compensation Committee
2003-2006
Former Director and Member of Nominating & Corporate Governance Committee
2003-2003
Former Director
2003-Present
Director
2006-2013
Former Director and Member of Compensation Committee
2010-Present
Director
2010-2014
Former Director and Member of Nominating & Corporate Governance Committee
2010-Present
Chairman, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
2014-Present
Director

Education*

MD
Medical University of Paris

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VRML:US $1.60 USD +0.05

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Russell Cummings Chief Executive Officer, Executive Director, and Member of Investment Committee
Imperial Innovations Group plc
210.0K GBP
Kevin Kowbell Chairman and Interim Chief Executive Officer
Health Discovery Corporation
--
Christopher J. Moreau Chief Executive Officer, President and Non Independent Director
Miraculins Inc.
C$247.9K
Rene A. Schena Chairman and Chief Executive Officer
Arrayit Corporation
--
Jan Groen Ph.D.Chief Executive Officer and Executive Director
MDxHealth SA
€470.7K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERMILLION INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.